We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.05B
Cap. Flow %
8.49%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UAL icon
2226
United Airlines
UAL
$39.2B
$683K ﹤0.01%
14,349
+11,878
+481% +$560K
PPTA
2227
Perpetua Resources
PPTA
$2.12B
$682K ﹤0.01%
+136,912
New +$764K
PHAS
2228
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$681K ﹤0.01%
+218,877
New +$730K
AZUL
2229
DELISTED
Azul
AZUL
$679K ﹤0.01%
+33,864
New +$742K
GDYN icon
2230
Grid Dynamics Holdings
GDYN
$535M
$678K ﹤0.01%
+23,221
New +$568K
NEXN
2231
Nexxen International
NEXN
$590M
$676K ﹤0.01%
+36,617
New +$762K
WTRG icon
2232
Essential Utilities
WTRG
$11.6B
$675K ﹤0.01%
+14,651
New +$710K
ARD
2233
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$675K ﹤0.01%
+26,498
New +$665K
GRTX
2234
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$673K ﹤0.01%
83,050
-33,458
-29% -$287K
GILD icon
2235
Gilead Sciences
GILD
$166B
$671K ﹤0.01%
9,600
-114,496
-92% -$8.04M
PUCKW
2236
CALL
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$670K ﹤0.01%
68,913
+26,326
+62% +$16.6K
F icon
2237
Ford
F
$62B
$669K ﹤0.01%
47,182
-2,724,772
-98% -$37.1M
UHT
2238
Universal Health Realty Income Trust
UHT
$629M
$667K ﹤0.01%
12,062
-724
-6% -$42.6K
VCIT icon
2239
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$667K ﹤0.01%
7,060
-60,698
-90% -$5.79M
GAIA icon
2240
Gaia
GAIA
$46.3M
$666K ﹤0.01%
70,235
-47,789
-40% -$504K
SAIA icon
2241
Saia
SAIA
$10.5B
$664K ﹤0.01%
2,789
-11,077
-80% -$2.56M
WSBC icon
2242
WesBanco
WSBC
$4.04B
$664K ﹤0.01%
+19,473
New +$645K
IYT icon
2243
iShares US Transportation ETF
IYT
$2.27B
$663K ﹤0.01%
10,908
-77,644
-88% -$4.91M
TGLS icon
2244
Tecnoglass
TGLS
$1.99B
$663K ﹤0.01%
30,518
-96,121
-76% -$2.02M
HTPA.WS
2245
CALL
DELISTED
Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HTPA.WS
$661K ﹤0.01%
66,662
CUBI icon
2246
Customers Bancorp
CUBI
$2.68B
$660K ﹤0.01%
+15,332
New +$597K
QTEK
2247
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
$660K ﹤0.01%
+66,352
New +$656K
PFGC icon
2248
Performance Food Group
PFGC
$18.2B
$658K ﹤0.01%
14,167
-34,158
-71% -$1.57M
COLM icon
2249
Columbia Sportswear
COLM
$3.22B
$657K ﹤0.01%
6,854
-62,335
-90% -$6.29M
CHTR icon
2250
PUT
Charter Communications
CHTR
$17.2B
$655K ﹤0.01%
900
+800
+800% +$607K

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.